Albemarle Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Los beneficios de Albemarle han disminuido a una tasa media anual de -33.8%, mientras que en la industria Chemicals los beneficios disminuyeron en un 3.8% anualmente. Los ingresos han ido creciendo a una tasa media de 7.1% al año.
Información clave
-33.80%
Tasa de crecimiento de los beneficios
-33.98%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 12.93% |
| Tasa de crecimiento de los ingresos | 7.13% |
| Rentabilidad financiera | -1.84% |
| Margen neto | -7.27% |
| Última actualización de beneficios | 31 Mar 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
Actualización de narrativa • May 13
ALB: Lithium Recovery And Cost Discipline Will Drive Future Re Rating
Albemarle's analyst price target has shifted from $245 to $264, with analysts pointing to recent broad based target raises and updated assumptions on lithium pricing, capital discipline, and a higher future P/E multiple as key drivers behind the change. Analyst Commentary Recent research points to a clear shift in tone around Albemarle, with a series of price target raises and selected upgrades framed around improving lithium fundamentals, tighter cost control, and a willingness to reward shareholders for disciplined capital allocation.Actualización de narrativa • Apr 29
ALB: Lithium Price Recovery And Cost Discipline Will Drive Bullish Re Rating
Analysts have nudged Albemarle's implied fair value estimate higher, with the target moving from $230 to $245 as they factor in slightly stronger revenue growth expectations, a modestly higher profit margin outlook, and updated P/E assumptions following a series of recent target hikes and mixed rating changes across the Street. Analyst Commentary Recent research on Albemarle shows a cluster of higher price targets and selective upgrades, even as a few firms trim targets or ratings.Seeking Alpha • Apr 21
Albemarle: BESS Demand May Make This The Last Lithium Cycle That Looks Like A Cycle
Summary Albemarle Corporation remains my top lithium pick, with a Buy rating reaffirmed amid a bullish macro and policy backdrop. Lithium price recovery, supply discipline, and structural demand from energy storage and EVs underpin ALB’s earnings leverage and margin expansion. Portfolio streamlining, cost savings, and U.S./China policy shifts create a favorable supply-demand setup for ALB stock, supporting a potential >100% upside scenario. Key risks include lithium price reversals and ALB’s elevated valuation, but diversified demand from stationary storage mitigates cyclicality concerns. Read the full article on Seeking AlphaActualización de narrativa • Apr 15
ALB: Lithium Price Recovery And Cost Discipline Will Support Bullish Re Rating
Analysts have raised their average price targets for Albemarle by double-digit dollar amounts, placing them in the $150 to $230 range. They cite higher lithium price assumptions, more constructive views on supply and demand, and ongoing cost discipline as key supports for the updated valuation inputs.Actualización de narrativa • Apr 01
ALB: Lithium Tightening And Cost Discipline Will Drive Bullish Re Rating Ahead
Analysts have nudged Albemarle's price targets higher across the board, with several firms lifting their views by $10 to more than $100, as they point to stronger lithium pricing, disciplined cost control, and improving sentiment around electric vehicle and energy storage demand. Analyst Commentary Bullish analysts are leaning into a more constructive view on Albemarle, with a cluster of upgrades and higher price targets tied to lithium pricing, cost discipline, and renewed interest in battery supply chains.
Actualización de narrativa • Mar 18
ALB: Lithium Price Rally Will Likely Curb Future Share Returns
The analyst price target for Albemarle has been revised higher to $126.39 from $75.00. Analysts point to stronger lithium pricing, tighter inventories, and ongoing cost and capital expenditure discipline as key reasons for the shift.Actualización de narrativa • Mar 03
ALB: Lithium Tightening And Price Recovery Will Support Re Rating Ahead
Albemarle's updated analyst price targets have moved higher, with several firms lifting their ranges into roughly the mid to low $200s as analysts point to stronger lithium pricing, tighter inventories, and what they view as improving supply and demand fundamentals for the commodity. Analyst Commentary Recent Street research on Albemarle shows a clear tilt toward more constructive views, with many bullish analysts increasing price targets across a wide range and several moving to more positive ratings.Actualización de narrativa • Feb 17
ALB: Lithium Supply Tightening And Pricing Recovery Will Drive Re Rating
The analyst price target for Albemarle has been raised to $230, up from $143.88, as analysts factor in stronger lithium pricing, improved supply and demand expectations, and updated views on margins and future price-to-earnings (P/E) multiples. Analyst Commentary Recent Street research on Albemarle has tilted more positive, with several bullish analysts lifting price targets and moving to more constructive ratings.Artículo de análisis • Feb 12
Newsflash: Albemarle Corporation (NYSE:ALB) Analysts Have Been Trimming Their Revenue Forecasts
The analysts covering Albemarle Corporation ( NYSE:ALB ) delivered a dose of negativity to shareholders today, by...
Actualización de narrativa • Feb 03
ALB: Future Returns Will Depend On Sustained Lithium Tightness And Pricing Power
The analyst price target for Albemarle has been raised from about $148 to roughly $173. This change reflects analysts' use of a slightly lower discount rate, modestly higher revenue growth assumptions, and a higher future P/E multiple, supported by a series of recent target hikes and upgrades tied to stronger lithium pricing and tightening supply expectations.Actualización de narrativa • Jan 20
ALB: Future Returns Will Hinge On Sustained Lithium Pricing Strength
The analyst price target for Albemarle has been raised from about $125.49 to roughly $147.79 as analysts factor in higher lithium price assumptions, improved profit margin expectations, and a lower future P/E multiple, supported by a broad wave of recent upgrades and target increases across major research firms. Analyst Commentary Recent research on Albemarle reflects a clear shift toward more constructive views, with several upgrades and higher targets built around revised lithium price decks, inventory tightness, and evolving demand themes such as energy storage and physical AI.Artículo de análisis • Jan 07
Albemarle Corporation (NYSE:ALB) Stocks Shoot Up 26% But Its P/S Still Looks Reasonable
Albemarle Corporation ( NYSE:ALB ) shares have continued their recent momentum with a 26% gain in the last month alone...Actualización de narrativa • Jan 05
ALB: Future Returns Will Depend On Lithium Pricing Outpacing Current Optimism
Narrative Update The analyst price target for Albemarle has increased from about $107 to roughly $125 as analysts incorporate updated lithium pricing assumptions, expectations for stronger medium-term earnings power, and slightly improved margin outlooks. These changes are reflected in a higher assumed future P/E multiple.Actualización de narrativa • Dec 18
ALB: Lithium Price Rebound Is Expected To Limit Future Share Upside
Analysts have raised our Albemarle fair value estimate to $75 from $58, reflecting higher projected lithium prices, improved demand expectations, and stronger medium term earnings power. Analyst Commentary Recent Street research on Albemarle has turned incrementally constructive on lithium pricing and near term earnings, but the overall tone remains balanced as many price targets and ratings embed limited upside from current levels.Actualización de narrativa • Dec 04
ALB: Future Returns Will Hinge On Sustained Lithium Price Recovery
Analysts have nudged our Albemarle fair value estimate higher to approximately $107 from about $103 per share, reflecting modestly improved lithium price expectations and slightly stronger long term earnings power despite still limited perceived upside. Analyst Commentary Street research has broadly shifted in a more constructive direction on Albemarle, with a series of target price increases reflecting higher assumed lithium prices and improved earnings power.Artículo de análisis • Nov 25
Albemarle (NYSE:ALB) Has Announced A Dividend Of $0.405
The board of Albemarle Corporation ( NYSE:ALB ) has announced that it will pay a dividend on the 2nd of January, with...Actualización de narrativa • Nov 20
ALB: Future Stock Performance Will Depend On Sustained Lithium Price Recovery
Albemarle's analyst price target has increased significantly, reflecting a new consensus valuation of approximately $103 per share. Analysts cite improved lithium demand expectations, earlier achievement of higher average sales prices, and enhanced market fundamentals as key drivers behind the upward revision.Artículo de análisis • Nov 18
Albemarle Corporation's (NYSE:ALB) 27% Share Price Surge Not Quite Adding Up
Albemarle Corporation ( NYSE:ALB ) shares have continued their recent momentum with a 27% gain in the last month alone...Actualización de narrativa • Nov 05
ALB: Future Earnings Outlook Will Balance Rising Lithium Prices And Chile Supply Uncertainties
The analyst price target for Albemarle has been revised upward from $92.92 to $96.45. Analysts point to favorable lithium price trends and improved earnings prospects as key drivers for the adjustment.Artículo de análisis • Oct 31
Albemarle (NYSE:ALB) Is Due To Pay A Dividend Of $0.405
The board of Albemarle Corporation ( NYSE:ALB ) has announced that it will pay a dividend on the 2nd of January, with...Actualización de narrativa • Oct 22
Analysts Adjust Targets for Albemarle Amid Lithium Market Shifts and Safety Incident in Chile
Albemarle's analyst price target has increased to $100 from $95, as analysts cite recent government investments and evolving lithium supply dynamics as factors supporting a higher fair value for the stock. Analyst Commentary Recent analyst reports on Albemarle reflect a mix of optimism and caution, as shifting lithium supply dynamics and significant government involvement continue to shape the company's outlook and valuation.Actualización de narrativa • Oct 08
Policy Tailwinds And Cost Cuts Will Unlock Lithium Potential
Albemarle's analyst price target has increased from approximately $86.65 to $87.79, as analysts cite improving lithium market conditions, particularly due to actions related to supply in China, and slightly stronger profit margins supporting the updated valuation. Analyst Commentary Recent analyst activity on Albemarle reflects a shift in sentiment in response to market dynamics and company-specific developments.Actualización de narrativa • Sep 23
Policy Tailwinds And Cost Cuts Will Unlock Lithium Potential
Analysts have slightly raised Albemarle’s price target from $85.47 to $86.65, citing increased uncertainty around global lithium supply due to China mine closures, which reduces downside risk and may support a sustained lithium price recovery. Analyst Commentary China mine site closures have increased uncertainty around global lithium supply, raising the potential for sustained improvement in lithium prices.Artículo de análisis • Sep 09
Albemarle (NYSE:ALB) Will Pay A Dividend Of $0.405
The board of Albemarle Corporation ( NYSE:ALB ) has announced that it will pay a dividend on the 1st of October, with...Artículo de análisis • Sep 01
Albemarle Corporation's (NYSE:ALB) Shares Climb 25% But Its Business Is Yet to Catch Up
Albemarle Corporation ( NYSE:ALB ) shares have continued their recent momentum with a 25% gain in the last month alone...Actualización de narrativa • Aug 28
Policy Tailwinds And Cost Cuts Will Unlock Lithium Potential
Upward revisions to Albemarle's price target reflect improved sentiment as China lithium mine closures introduce upside risk to lithium prices and temper bearish views, resulting in a consensus analyst price target increase from $83.79 to $85.01. Analyst Commentary Recent China lithium mine site closures have introduced upside risk to lithium prices, challenging the prolonged bearish outlook for Albemarle.Artículo de análisis • Aug 15
Albemarle (NYSE:ALB) Is Due To Pay A Dividend Of $0.405
Albemarle Corporation ( NYSE:ALB ) has announced that it will pay a dividend of $0.405 per share on the 1st of October...Artículo de análisis • Jul 31
Albemarle (NYSE:ALB) Is Paying Out A Dividend Of $0.405
The board of Albemarle Corporation ( NYSE:ALB ) has announced that it will pay a dividend of $0.405 per share on the...Artículo de análisis • Jul 18
Albemarle Corporation's (NYSE:ALB) 27% Share Price Surge Not Quite Adding Up
Despite an already strong run, Albemarle Corporation ( NYSE:ALB ) shares have been powering on, with a gain of 27% in...Artículo de análisis • Jul 02
Is Albemarle (NYSE:ALB) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Artículo de análisis • May 20
Is It Time To Consider Buying Albemarle Corporation (NYSE:ALB)?
Albemarle Corporation ( NYSE:ALB ), is not the largest company out there, but it saw a double-digit share price rise of...
Nueva narrativa • Apr 22
Optimized Conversion Network And Capex Cuts Will Secure Lithium Stability
Optimization and cost efficiency efforts could improve Albemarle's margins despite volatile lithium prices, enhancing earnings stability.Seeking Alpha • Apr 10
Albemarle: Tariff War Triggers Richer Yields And Improved Upside Potential
Summary ALB has fallen drastically since 2022 peaks, thanks to the moderating lithium spot prices, the over-supply issues in 2025, and the intensified tariff/trade war. This is on top of the potential impacts on near-term energy storage/EV demand, since lithium may be twice tariffed attributed to the global mining/ packaging/ final product development. Even so, ALB appears to be well capitalized to weather the near-term headwinds, thanks to the healthier balance sheet and Talison Joint Venture being adj EBITDA accretive from 2026/2027 onwards. This is on top of the projected lithium deficit from 2026 onwards, with it likely to trigger higher spot prices and improved top/bottom lines then. With ALB now offering a relatively rich total operational return at double digits, we are upgrading to a cautious Buy with numerous caveats. Read the full article on Seeking AlphaSeeking Alpha • Feb 11
Albemarle: Stock Lines Up For A Secular Buy
Summary If you bought Albemarle for its low P/E ratio when it was at $300, you should sell now as earnings will be negative. But investors who understand cyclicality look at the price-to-sales ratio and would buy Albemarle today and avoid NVIDIA. We go over how a flat price generates a 22% annualized yield here and also look at the convertible shares yielding 9.6%. Read the full article on Seeking AlphaSeeking Alpha • Dec 10
Albemarle Stock Is My Top Pick For Next Year And For The Rest Of The Decade
Summary Lithium prices have dropped 85% from their peak, causing Albemarle's stock to fall by two-thirds, but a market turnaround is likely to happen soon, given that miners are cutting costs. Continued lithium demand growth, even as miners are cutting back on capital spending, makes for a potentially robust lithium price upswing in the near future. Albemarle's finances are strained, showing significant losses, but the company is cutting capital spending to improve future financial results in response to low lithium prices, which should improve profitability. While there are many downside risks for the lithium market and multinational companies like Albemarle, such as nationalization risks, and risks of trade disruptions, the downside is limited, while the upside potential is substantial. The low downside risk, high-upside potential combination makes Albemarle one of my top picks to outperform next year and for the rest of this decade. Read the full article on Seeking AlphaSeeking Alpha • Nov 29
Albemarle Preferred Shares Are Awful, Get Better Yield This Way
Summary Mandatory convertible preferred shares like ALB.PR.A are almost as risky as common shares. Most investors are in it for the fixed coupon and don't understand their potential losses. We saw this in the case of Algonquin mandatory convertibles and even in the case of Paramount mandatory convertibles. We suggest a better way. Read the full article on Seeking AlphaSeeking Alpha • Nov 20
Albemarle: Troubles Persist, Best To Stay Away
Summary Albemarle Corporation, a leader in lithium mining, faces challenges as lithium prices have plunged, impacting revenue and profitability. The company has negative margins and generates negative Free Cash Flow, with Working Capital Changes temporarily masking deeper financial issues. Management is optimistic, targeting $300-$400 million in cost reductions and a 50% cut in 2025 capital expenditures, but remains vague on the 2025 outlook. I maintain a STRONG SELL rating due to ongoing negative Free Cash Flow and reliance on unsustainable Working Capital Changes for short-term gains. Read the full article on Seeking AlphaDesglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero Albemarle. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 26 | 5,495 | -400 | 559 | 46 |
| 31 Dec 25 | 5,143 | -677 | 543 | 51 |
| 30 Sep 25 | 4,946 | -188 | 503 | 59 |
| 30 Jun 25 | 4,993 | -1,096 | 523 | 69 |
| 31 Mar 25 | 5,094 | -1,307 | 558 | 77 |
| 31 Dec 24 | 5,378 | -1,316 | 595 | 87 |
| 30 Sep 24 | 6,502 | -1,967 | 647 | 89 |
| 30 Jun 24 | 7,458 | -554 | 655 | 88 |
| 31 Mar 24 | 8,398 | 326 | 654 | 89 |
| 31 Dec 23 | 9,617 | 1,573 | 869 | 86 |
| 30 Sep 23 | 9,882 | 3,324 | 570 | 83 |
| 30 Jun 23 | 9,663 | 3,918 | 532 | 80 |
| 31 Mar 23 | 8,773 | 3,675 | 483 | 76 |
| 31 Dec 22 | 7,320 | 2,690 | 439 | 72 |
| 30 Sep 22 | 5,593 | 1,554 | 393 | 64 |
| 30 Jun 22 | 4,332 | 264 | 365 | 59 |
| 31 Mar 22 | 3,626 | 281 | 363 | 55 |
| 31 Dec 21 | 3,328 | 124 | 333 | 54 |
| 30 Sep 21 | 3,313 | 212 | 450 | 57 |
| 30 Jun 21 | 3,229 | 703 | 439 | 58 |
| 31 Mar 21 | 3,219 | 364 | 418 | 58 |
| 31 Dec 20 | 3,129 | 376 | 427 | 59 |
| 30 Sep 20 | 3,242 | 382 | 411 | 58 |
| 30 Jun 20 | 3,375 | 438 | 430 | 60 |
| 31 Mar 20 | 3,496 | 507 | 453 | 59 |
| 31 Dec 19 | 3,589 | 533 | 470 | 58 |
| 30 Sep 19 | 3,519 | 572 | 440 | 60 |
| 30 Jun 19 | 3,417 | 547 | 432 | 61 |
| 31 Mar 19 | 3,385 | 695 | 417 | 64 |
| 31 Dec 18 | 3,375 | 694 | 415 | 70 |
| 30 Sep 18 | 3,311 | 346 | 410 | 75 |
| 30 Jun 18 | 3,288 | 335 | 416 | 80 |
| 31 Mar 18 | 3,172 | 135 | 421 | 81 |
| 31 Dec 17 | 3,072 | 55 | 420 | 79 |
| 30 Sep 17 | 2,911 | 315 | 431 | 77 |
| 30 Jun 17 | 2,810 | 302 | 416 | 75 |
| 31 Mar 17 | 2,742 | 282 | 396 | 78 |
| 31 Dec 16 | 2,677 | 442 | 355 | 79 |
| 30 Sep 16 | 2,703 | 560 | 303 | 82 |
| 30 Jun 16 | 2,742 | 510 | 297 | 84 |
| 31 Mar 16 | 2,791 | 468 | 299 | 86 |
| 31 Dec 15 | 2,826 | 302 | 300 | 89 |
| 30 Sep 15 | 2,702 | 124 | 397 | 89 |
| 30 Jun 15 | 2,652 | 149 | 382 | 89 |
Ingresos de calidad: ALB actualmente no es rentable.
Margen de beneficios creciente: ALB actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: ALB no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 33.8% al año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de ALB en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: ALB no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Chemicals (-3%).
Rentabilidad financiera
Alta ROE: ALB tiene una rentabilidad financiera negativa (-1.84%), ya que actualmente no es rentable.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/14 05:58 |
| Precio de las acciones al final del día | 2026/05/14 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Albemarle Corporation está cubierta por 37 analistas. 18 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| William Selesky | Argus Research Company |
| Benjamin Kallo | Baird |
| Andres Castanos-Mollor | Berenberg |